← Leaderboards
Neera Tewari-Singh
University Of Colorado Denver
$3,731,189
Attributed
$5,430,475
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2017–25$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,430,475 · 5
By mechanism
R01$2,933,326 · 2
U01$1,422,295 · 1
R21$1,074,854 · 2
Top collaborators
- Carrie German4 shared
- Alison K Bauer1 shared
- Jared Michael Brown1 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Rajesh Agarwal$27,337,251
- Kirsten H Limesand$6,799,601
- Livia Agnes Veress$8,631,906
- Mary Elaine Reyland$13,618,689
- Kevin J. Staley$35,882,339
Others in their field
Other Emerging Leaders on “Toxic Effect”
- Matthew Johnson · Duke University$56,071,536
- John Damon Chodera · Sloan-Kettering Inst Can Research$25,853,758
- Kristin Aillon · Midwest Research Institute$24,228,962
- Bronwen Shaw · Medical College Of Wisconsin$19,182,557
- Xinhua Li · Nano Terra, Inc.$17,491,533
- Thomas Denny · Duke University$16,626,143
Research focus
Toxic EffectTissuesPathway InteractionsInflammationAcuteInjuryOrganEffective TherapyBiological MarkersResponseVesicantsIn VivoPublishingTreatment StrategyInflammatoryNew Therapeutic TargetTherapeutic TargetChemical AgentsCytokineMustardDesignNecrosisTherapeutic InterventionInflammatory Response
Grant awards (15)
Mast Cell Activation as a Common Mechanism of Pulmonary Toxicity by Chemical Threat Agents$1,395,741
R01 · FY2025 · ES
Understanding Mustard Vesicants Distribution and Toxicity in the Eye Using In Vivo and In Silico Models$453,286
R01 · FY2025 · EY · contact PI
Understanding Mustard Vesicants Distribution and Toxicity in the Eye Using In Vivo and In Silico Models$156,998
R01 · FY2025 · EY · contact PI
Understanding Mustard Vesicants Distribution and Toxicity in the Eye Using In Vivo and In Silico Models$460,271
R01 · FY2024 · EY · contact PI
Understanding Mustard Vesicants Distribution and Toxicity in the Eye Using In Vivo and In Silico Models$467,030
R01 · FY2023 · EY · contact PI
Treatment strategies for ocular toxicity from chloropicrin$156,991
R21 · FY2023 · EY · contact PI
Treatment strategies for ocular toxicity from chloropicrin$234,750
R21 · FY2022 · EY · contact PI
Targeted Therapeutic Approaches to Counteract Toxicity from Phosgene Oxime Skin Exposure$469,390
U01 · FY2021 · AR · contact PI
Treatment strategies for ocular toxicity from chloropicrin$195,625
R21 · FY2021 · EY · contact PI
Targeted Therapeutic Approaches to Counteract Toxicity from Phosgene Oxime Skin Exposure$474,397
U01 · FY2020 · AR · contact PI
Targeted Therapeutic Approaches to Counteract Toxicity from Phosgene Oxime Skin Exposure$478,508
U01 · FY2019 · AR · contact PI
Phosgene Oxime Cutaneous Toxicity and Mechanisms to Identify Therapeutic Targets$240,736
R21 · FY2018 · AR · contact PI
Phosgene Oxime Cutaneous Toxicity and Mechanisms to Identify Therapeutic Targets$28,775
R21 · FY2018 · AR · contact PI
Phosgene Oxime Cutaneous Toxicity and Mechanisms to Identify Therapeutic Targets$4,152
R21 · FY2018 · AR · contact PI
Phosgene Oxime Cutaneous Toxicity and Mechanisms to Identify Therapeutic Targets$213,825
R21 · FY2017 · AR · contact PI